nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—P-Glycoprotein Inhibitors—Cyclosporine—psoriasis	0.305	0.521	CiPCiCtD
Amiodarone—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.28	0.479	CiPCiCtD
Amiodarone—CYP1A1—Clobetasol propionate—psoriasis	0.0304	0.102	CbGbCtD
Amiodarone—CYP2A6—Methoxsalen—psoriasis	0.0187	0.0629	CbGbCtD
Amiodarone—CYP1A1—Methoxsalen—psoriasis	0.016	0.0538	CbGbCtD
Amiodarone—CYP2C8—Tazarotene—psoriasis	0.0143	0.0482	CbGbCtD
Amiodarone—CYP3A5—Beclomethasone—psoriasis	0.0138	0.0466	CbGbCtD
Amiodarone—CYP1A2—Clobetasol propionate—psoriasis	0.0136	0.0457	CbGbCtD
Amiodarone—CYP1A1—Cholecalciferol—psoriasis	0.0106	0.0356	CbGbCtD
Amiodarone—CYP2A6—Prednisolone—psoriasis	0.00909	0.0306	CbGbCtD
Amiodarone—CYP1A2—Methoxsalen—psoriasis	0.00713	0.024	CbGbCtD
Amiodarone—CYP2D6—Hydroxyurea—psoriasis	0.00643	0.0216	CbGbCtD
Amiodarone—CYP2C8—Cholecalciferol—psoriasis	0.0061	0.0206	CbGbCtD
Amiodarone—CYP3A7—Hydrocortisone—psoriasis	0.00589	0.0198	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.00589	0.0198	CbGbCtD
Amiodarone—CYP3A7—Cyclosporine—psoriasis	0.00556	0.0187	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00556	0.0187	CbGbCtD
Amiodarone—CYP3A5—Mycophenolate mofetil—psoriasis	0.0055	0.0185	CbGbCtD
Amiodarone—CYP2A6—Dexamethasone—psoriasis	0.00536	0.018	CbGbCtD
Amiodarone—CYP2C8—Mycophenolate mofetil—psoriasis	0.00529	0.0178	CbGbCtD
Amiodarone—CYP2C19—Cholecalciferol—psoriasis	0.00512	0.0172	CbGbCtD
Amiodarone—CYP3A4—Calcitriol—psoriasis	0.00481	0.0162	CbGbCtD
Amiodarone—CYP1A1—Dexamethasone—psoriasis	0.00458	0.0154	CbGbCtD
Amiodarone—CYP3A5—Hydrocortisone—psoriasis	0.00442	0.0149	CbGbCtD
Amiodarone—CYP2C9—Cholecalciferol—psoriasis	0.00426	0.0143	CbGbCtD
Amiodarone—CYP2C8—Hydrocortisone—psoriasis	0.00425	0.0143	CbGbCtD
Amiodarone—CYP3A5—Cyclosporine—psoriasis	0.00417	0.014	CbGbCtD
Amiodarone—CYP2C8—Cyclosporine—psoriasis	0.00401	0.0135	CbGbCtD
Amiodarone—CYP2D6—Cholecalciferol—psoriasis	0.00389	0.0131	CbGbCtD
Amiodarone—CYP3A4—Methoxsalen—psoriasis	0.00374	0.0126	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00366	0.0123	CbGbCtD
Amiodarone—CYP3A7—Dexamethasone—psoriasis	0.00366	0.0123	CbGbCtD
Amiodarone—ABCB1—Mycophenolate mofetil—psoriasis	0.00358	0.0121	CbGbCtD
Amiodarone—CYP2C19—Prednisone—psoriasis	0.00355	0.012	CbGbCtD
Amiodarone—CYP2C19—Cyclosporine—psoriasis	0.00337	0.0113	CbGbCtD
Amiodarone—ABCB1—Betamethasone—psoriasis	0.00307	0.0103	CbGbCtD
Amiodarone—ABCB1—Prednisolone—psoriasis	0.00303	0.0102	CbGbCtD
Amiodarone—ABCB1—Hydrocortisone—psoriasis	0.00288	0.00968	CbGbCtD
Amiodarone—ABCB1—Prednisone—psoriasis	0.00286	0.00964	CbGbCtD
Amiodarone—CYP2C9—Cyclosporine—psoriasis	0.0028	0.00942	CbGbCtD
Amiodarone—CYP3A5—Dexamethasone—psoriasis	0.00275	0.00925	CbGbCtD
Amiodarone—ABCB1—Cyclosporine—psoriasis	0.00272	0.00914	CbGbCtD
Amiodarone—CYP2C8—Dexamethasone—psoriasis	0.00264	0.00889	CbGbCtD
Amiodarone—CYP2D6—Cyclosporine—psoriasis	0.00256	0.00861	CbGbCtD
Amiodarone—CYP3A4—Cholecalciferol—psoriasis	0.00248	0.00834	CbGbCtD
Amiodarone—CYP2C19—Dexamethasone—psoriasis	0.00222	0.00746	CbGbCtD
Amiodarone—CYP3A4—Triamcinolone—psoriasis	0.00215	0.00723	CbGbCtD
Amiodarone—CYP3A4—Mycophenolate mofetil—psoriasis	0.00215	0.00723	CbGbCtD
Amiodarone—CYP2C9—Dexamethasone—psoriasis	0.00184	0.0062	CbGbCtD
Amiodarone—CYP3A4—Betamethasone—psoriasis	0.00184	0.0062	CbGbCtD
Amiodarone—CYP3A4—Prednisolone—psoriasis	0.00182	0.00612	CbGbCtD
Amiodarone—ABCB1—Dexamethasone—psoriasis	0.00179	0.00602	CbGbCtD
Amiodarone—CYP3A4—Hydrocortisone—psoriasis	0.00172	0.0058	CbGbCtD
Amiodarone—CYP3A4—Prednisone—psoriasis	0.00172	0.00578	CbGbCtD
Amiodarone—CYP2D6—Dexamethasone—psoriasis	0.00168	0.00567	CbGbCtD
Amiodarone—CYP3A4—Cyclosporine—psoriasis	0.00163	0.00548	CbGbCtD
Amiodarone—ABCB1—Methotrexate—psoriasis	0.00144	0.00484	CbGbCtD
Amiodarone—CYP3A4—Dexamethasone—psoriasis	0.00107	0.00361	CbGbCtD
Amiodarone—SIGMAR1—Levonorgestrel—Hydrocortisone—psoriasis	0.000276	1	CbGdCrCtD
Amiodarone—EBP—Metabolism—CYP2S1—psoriasis	7.29e-05	0.00277	CbGpPWpGaD
Amiodarone—CYP1A1—Biological oxidations—CYP2S1—psoriasis	7.24e-05	0.00275	CbGpPWpGaD
Amiodarone—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	7.14e-05	0.00271	CbGpPWpGaD
Amiodarone—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	7.13e-05	0.00271	CbGpPWpGaD
Amiodarone—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	7.02e-05	0.00267	CbGpPWpGaD
Amiodarone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	6.71e-05	0.00255	CbGpPWpGaD
Amiodarone—CYP2C8—Biological oxidations—CYP2S1—psoriasis	6.64e-05	0.00252	CbGpPWpGaD
Amiodarone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	6.62e-05	0.00251	CbGpPWpGaD
Amiodarone—CACNA1H—Corticotropin-releasing hormone—NFKB1—psoriasis	6.55e-05	0.00249	CbGpPWpGaD
Amiodarone—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	6.55e-05	0.00249	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—CXCL8—psoriasis	6.54e-05	0.00248	CbGpPWpGaD
Amiodarone—ADRB1—Melatonin metabolism and effects—NFKB1—psoriasis	6.42e-05	0.00244	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	6.37e-05	0.00242	CbGpPWpGaD
Amiodarone—CYP1A1—Tryptophan metabolism—CAT—psoriasis	6.25e-05	0.00237	CbGpPWpGaD
Amiodarone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.17e-05	0.00234	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—NDUFA5—psoriasis	6.11e-05	0.00232	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—JUN—psoriasis	6.08e-05	0.00231	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—CARM1—psoriasis	6.01e-05	0.00228	CbGpPWpGaD
Amiodarone—CYP2C19—Biological oxidations—CYP2S1—psoriasis	5.93e-05	0.00225	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.85e-05	0.00222	CbGpPWpGaD
Amiodarone—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	5.85e-05	0.00222	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—HCAR2—psoriasis	5.8e-05	0.0022	CbGpPWpGaD
Amiodarone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.76e-05	0.00219	CbGpPWpGaD
Amiodarone—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	5.75e-05	0.00218	CbGpPWpGaD
Amiodarone—CYP2D6—Biological oxidations—CYP2S1—psoriasis	5.45e-05	0.00207	CbGpPWpGaD
Amiodarone—CYP2A6—NRF2 pathway—TGFA—psoriasis	5.41e-05	0.00205	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—CYP2S1—psoriasis	5.4e-05	0.00205	CbGpPWpGaD
Amiodarone—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	5.38e-05	0.00204	CbGpPWpGaD
Amiodarone—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	5.33e-05	0.00202	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—VEGFA—psoriasis	5.31e-05	0.00202	CbGpPWpGaD
Amiodarone—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	5.29e-05	0.00201	CbGpPWpGaD
Amiodarone—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	5.26e-05	0.00199	CbGpPWpGaD
Amiodarone—CACNA1H—NCAM signaling for neurite out-growth—IL6—psoriasis	5.24e-05	0.00199	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—IL10—psoriasis	5.2e-05	0.00198	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—CYP2S1—psoriasis	5.19e-05	0.00197	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—VDR—psoriasis	5.19e-05	0.00197	CbGpPWpGaD
Amiodarone—THRB—Generic Transcription Pathway—VDR—psoriasis	5.19e-05	0.00197	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	5.15e-05	0.00195	CbGpPWpGaD
Amiodarone—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	5.06e-05	0.00192	CbGpPWpGaD
Amiodarone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	4.95e-05	0.00188	CbGpPWpGaD
Amiodarone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	4.93e-05	0.00187	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—HLA-C—psoriasis	4.92e-05	0.00187	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—IL13—psoriasis	4.89e-05	0.00186	CbGpPWpGaD
Amiodarone—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—psoriasis	4.75e-05	0.0018	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—CYP2S1—psoriasis	4.62e-05	0.00175	CbGpPWpGaD
Amiodarone—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	4.55e-05	0.00173	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—TNF—psoriasis	4.55e-05	0.00173	CbGpPWpGaD
Amiodarone—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	4.55e-05	0.00173	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—IL17A—psoriasis	4.5e-05	0.00171	CbGpPWpGaD
Amiodarone—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	4.48e-05	0.0017	CbGpPWpGaD
Amiodarone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.3e-05	0.00163	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—CARM1—psoriasis	4.19e-05	0.00159	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—CARM1—psoriasis	4.19e-05	0.00159	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—IL12B—psoriasis	4.18e-05	0.00159	CbGpPWpGaD
Amiodarone—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	4.18e-05	0.00159	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—HLA-E—psoriasis	4.08e-05	0.00155	CbGpPWpGaD
Amiodarone—CYP1A1—Oxidative Stress—NFKB1—psoriasis	4.06e-05	0.00154	CbGpPWpGaD
Amiodarone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.02e-05	0.00153	CbGpPWpGaD
Amiodarone—CYP1A2—Tryptophan metabolism—CAT—psoriasis	3.98e-05	0.00151	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	3.96e-05	0.0015	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.82e-05	0.00145	CbGpPWpGaD
Amiodarone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.8e-05	0.00144	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—IL6—psoriasis	3.67e-05	0.00139	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—PPARG—psoriasis	3.62e-05	0.00137	CbGpPWpGaD
Amiodarone—THRB—Generic Transcription Pathway—PPARG—psoriasis	3.62e-05	0.00137	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—CYP2S1—psoriasis	3.56e-05	0.00135	CbGpPWpGaD
Amiodarone—EBP—Metabolism—CARM1—psoriasis	3.56e-05	0.00135	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	3.52e-05	0.00133	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	3.47e-05	0.00132	CbGpPWpGaD
Amiodarone—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	3.47e-05	0.00132	CbGpPWpGaD
Amiodarone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.43e-05	0.0013	CbGpPWpGaD
Amiodarone—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	3.42e-05	0.0013	CbGpPWpGaD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	3.41e-05	0.00129	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	3.38e-05	0.00128	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.33e-05	0.00126	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—HCAR2—psoriasis	3.28e-05	0.00124	CbGpPWpGaD
Amiodarone—Malaise—Dexamethasone—psoriasis	3.23e-05	0.000355	CcSEcCtD
Amiodarone—Anaphylactic shock—Triamcinolone—psoriasis	3.22e-05	0.000354	CcSEcCtD
Amiodarone—Oedema—Triamcinolone—psoriasis	3.22e-05	0.000354	CcSEcCtD
Amiodarone—Vertigo—Dexamethasone—psoriasis	3.22e-05	0.000353	CcSEcCtD
Amiodarone—Vertigo—Betamethasone—psoriasis	3.22e-05	0.000353	CcSEcCtD
Amiodarone—Constipation—Mycophenolate mofetil—psoriasis	3.21e-05	0.000353	CcSEcCtD
Amiodarone—Pain—Mycophenolate mofetil—psoriasis	3.21e-05	0.000353	CcSEcCtD
Amiodarone—Arrhythmia—Prednisone—psoriasis	3.2e-05	0.000352	CcSEcCtD
Amiodarone—Infection—Triamcinolone—psoriasis	3.2e-05	0.000352	CcSEcCtD
Amiodarone—Sweating—Methotrexate—psoriasis	3.2e-05	0.000351	CcSEcCtD
Amiodarone—Hypotension—Hydrocortisone—psoriasis	3.2e-05	0.000351	CcSEcCtD
Amiodarone—Feeling abnormal—Cyclosporine—psoriasis	3.17e-05	0.000348	CcSEcCtD
Amiodarone—Shock—Triamcinolone—psoriasis	3.17e-05	0.000348	CcSEcCtD
Amiodarone—Insomnia—Prednisolone—psoriasis	3.17e-05	0.000348	CcSEcCtD
Amiodarone—Alopecia—Prednisone—psoriasis	3.17e-05	0.000348	CcSEcCtD
Amiodarone—Gastrointestinal pain—Cyclosporine—psoriasis	3.15e-05	0.000346	CcSEcCtD
Amiodarone—Dizziness—Mycophenolic acid—psoriasis	3.15e-05	0.000346	CcSEcCtD
Amiodarone—Paraesthesia—Prednisolone—psoriasis	3.15e-05	0.000345	CcSEcCtD
Amiodarone—Tachycardia—Triamcinolone—psoriasis	3.14e-05	0.000345	CcSEcCtD
Amiodarone—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	3.14e-05	0.00119	CbGpPWpGaD
Amiodarone—Erythema—Prednisone—psoriasis	3.12e-05	0.000343	CcSEcCtD
Amiodarone—Hyperhidrosis—Triamcinolone—psoriasis	3.11e-05	0.000342	CcSEcCtD
Amiodarone—Agranulocytosis—Methotrexate—psoriasis	3.11e-05	0.000342	CcSEcCtD
Amiodarone—Feeling abnormal—Mycophenolate mofetil—psoriasis	3.1e-05	0.00034	CcSEcCtD
Amiodarone—Insomnia—Hydrocortisone—psoriasis	3.09e-05	0.00034	CcSEcCtD
Amiodarone—CYP3A4—Tryptophan metabolism—CAT—psoriasis	3.08e-05	0.00117	CbGpPWpGaD
Amiodarone—Paraesthesia—Hydrocortisone—psoriasis	3.07e-05	0.000337	CcSEcCtD
Amiodarone—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	3.07e-05	0.000337	CcSEcCtD
Amiodarone—CACNA1H—Axon guidance—TYK2—psoriasis	3.07e-05	0.00117	CbGpPWpGaD
Amiodarone—Urticaria—Cyclosporine—psoriasis	3.06e-05	0.000336	CcSEcCtD
Amiodarone—ABCB1—Allograft Rejection—IL10—psoriasis	3.06e-05	0.00116	CbGpPWpGaD
Amiodarone—Body temperature increased—Cyclosporine—psoriasis	3.04e-05	0.000334	CcSEcCtD
Amiodarone—Abdominal pain—Cyclosporine—psoriasis	3.04e-05	0.000334	CcSEcCtD
Amiodarone—Anxiety—Betamethasone—psoriasis	3.04e-05	0.000334	CcSEcCtD
Amiodarone—Anxiety—Dexamethasone—psoriasis	3.04e-05	0.000334	CcSEcCtD
Amiodarone—Vomiting—Mycophenolic acid—psoriasis	3.03e-05	0.000332	CcSEcCtD
Amiodarone—ADRB1—GPCR ligand binding—CCL20—psoriasis	3.01e-05	0.00114	CbGpPWpGaD
Amiodarone—Discomfort—Dexamethasone—psoriasis	3.01e-05	0.000331	CcSEcCtD
Amiodarone—Discomfort—Betamethasone—psoriasis	3.01e-05	0.000331	CcSEcCtD
Amiodarone—Dyspepsia—Hydrocortisone—psoriasis	3.01e-05	0.000331	CcSEcCtD
Amiodarone—Rash—Mycophenolic acid—psoriasis	3e-05	0.00033	CcSEcCtD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3e-05	0.00114	CbGpPWpGaD
Amiodarone—Dermatitis—Mycophenolic acid—psoriasis	3e-05	0.000329	CcSEcCtD
Amiodarone—Pain—Prednisolone—psoriasis	3e-05	0.000329	CcSEcCtD
Amiodarone—Hepatitis—Methotrexate—psoriasis	2.99e-05	0.000329	CcSEcCtD
Amiodarone—Urticaria—Mycophenolate mofetil—psoriasis	2.98e-05	0.000328	CcSEcCtD
Amiodarone—Headache—Mycophenolic acid—psoriasis	2.98e-05	0.000327	CcSEcCtD
Amiodarone—ADRB1—Signaling by GPCR—HCAR2—psoriasis	2.98e-05	0.00113	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—IL4—psoriasis	2.97e-05	0.00113	CbGpPWpGaD
Amiodarone—Decreased appetite—Hydrocortisone—psoriasis	2.97e-05	0.000327	CcSEcCtD
Amiodarone—Abdominal pain—Mycophenolate mofetil—psoriasis	2.97e-05	0.000326	CcSEcCtD
Amiodarone—Body temperature increased—Mycophenolate mofetil—psoriasis	2.97e-05	0.000326	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Hydrocortisone—psoriasis	2.95e-05	0.000324	CcSEcCtD
Amiodarone—Fatigue—Hydrocortisone—psoriasis	2.95e-05	0.000324	CcSEcCtD
Amiodarone—Vision blurred—Prednisone—psoriasis	2.94e-05	0.000323	CcSEcCtD
Amiodarone—Pain—Hydrocortisone—psoriasis	2.93e-05	0.000321	CcSEcCtD
Amiodarone—Oedema—Dexamethasone—psoriasis	2.92e-05	0.000321	CcSEcCtD
Amiodarone—Anaphylactic shock—Betamethasone—psoriasis	2.92e-05	0.000321	CcSEcCtD
Amiodarone—Anaphylactic shock—Dexamethasone—psoriasis	2.92e-05	0.000321	CcSEcCtD
Amiodarone—Oedema—Betamethasone—psoriasis	2.92e-05	0.000321	CcSEcCtD
Amiodarone—Insomnia—Triamcinolone—psoriasis	2.91e-05	0.00032	CcSEcCtD
Amiodarone—ABCB1—Allograft Rejection—HLA-B—psoriasis	2.91e-05	0.0011	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	2.91e-05	0.0011	CbGpPWpGaD
Amiodarone—Infection—Dexamethasone—psoriasis	2.9e-05	0.000319	CcSEcCtD
Amiodarone—Infection—Betamethasone—psoriasis	2.9e-05	0.000319	CcSEcCtD
Amiodarone—Ill-defined disorder—Prednisone—psoriasis	2.89e-05	0.000318	CcSEcCtD
Amiodarone—Paraesthesia—Triamcinolone—psoriasis	2.89e-05	0.000318	CcSEcCtD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.89e-05	0.0011	CbGpPWpGaD
Amiodarone—Feeling abnormal—Prednisolone—psoriasis	2.89e-05	0.000317	CcSEcCtD
Amiodarone—Visual impairment—Methotrexate—psoriasis	2.89e-05	0.000317	CcSEcCtD
Amiodarone—Shock—Dexamethasone—psoriasis	2.88e-05	0.000316	CcSEcCtD
Amiodarone—Shock—Betamethasone—psoriasis	2.88e-05	0.000316	CcSEcCtD
Amiodarone—Dyspnoea—Triamcinolone—psoriasis	2.87e-05	0.000315	CcSEcCtD
Amiodarone—CACNA1H—Developmental Biology—LEP—psoriasis	2.87e-05	0.00109	CbGpPWpGaD
Amiodarone—Agitation—Prednisone—psoriasis	2.87e-05	0.000315	CcSEcCtD
Amiodarone—Thrombocytopenia—Dexamethasone—psoriasis	2.86e-05	0.000314	CcSEcCtD
Amiodarone—Thrombocytopenia—Betamethasone—psoriasis	2.86e-05	0.000314	CcSEcCtD
Amiodarone—Tachycardia—Dexamethasone—psoriasis	2.85e-05	0.000313	CcSEcCtD
Amiodarone—Tachycardia—Betamethasone—psoriasis	2.85e-05	0.000313	CcSEcCtD
Amiodarone—Angioedema—Prednisone—psoriasis	2.85e-05	0.000313	CcSEcCtD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.85e-05	0.00108	CbGpPWpGaD
Amiodarone—Hypersensitivity—Cyclosporine—psoriasis	2.84e-05	0.000312	CcSEcCtD
Amiodarone—Dyspepsia—Triamcinolone—psoriasis	2.84e-05	0.000311	CcSEcCtD
Amiodarone—Erythema multiforme—Methotrexate—psoriasis	2.83e-05	0.000311	CcSEcCtD
Amiodarone—Nausea—Mycophenolic acid—psoriasis	2.83e-05	0.00031	CcSEcCtD
Amiodarone—Hyperhidrosis—Dexamethasone—psoriasis	2.83e-05	0.00031	CcSEcCtD
Amiodarone—Hyperhidrosis—Betamethasone—psoriasis	2.83e-05	0.00031	CcSEcCtD
Amiodarone—Feeling abnormal—Hydrocortisone—psoriasis	2.82e-05	0.00031	CcSEcCtD
Amiodarone—Malaise—Prednisone—psoriasis	2.81e-05	0.000309	CcSEcCtD
Amiodarone—Vertigo—Prednisone—psoriasis	2.8e-05	0.000308	CcSEcCtD
Amiodarone—Gastrointestinal pain—Hydrocortisone—psoriasis	2.8e-05	0.000307	CcSEcCtD
Amiodarone—Tinnitus—Methotrexate—psoriasis	2.79e-05	0.000307	CcSEcCtD
Amiodarone—Anorexia—Betamethasone—psoriasis	2.79e-05	0.000306	CcSEcCtD
Amiodarone—Anorexia—Dexamethasone—psoriasis	2.79e-05	0.000306	CcSEcCtD
Amiodarone—Urticaria—Prednisolone—psoriasis	2.78e-05	0.000306	CcSEcCtD
Amiodarone—Fatigue—Triamcinolone—psoriasis	2.78e-05	0.000305	CcSEcCtD
Amiodarone—Hypersensitivity—Mycophenolate mofetil—psoriasis	2.77e-05	0.000304	CcSEcCtD
Amiodarone—Asthenia—Cyclosporine—psoriasis	2.76e-05	0.000303	CcSEcCtD
Amiodarone—Pain—Triamcinolone—psoriasis	2.76e-05	0.000303	CcSEcCtD
Amiodarone—Hypotension—Betamethasone—psoriasis	2.73e-05	0.0003	CcSEcCtD
Amiodarone—Hypotension—Dexamethasone—psoriasis	2.73e-05	0.0003	CcSEcCtD
Amiodarone—Pruritus—Cyclosporine—psoriasis	2.72e-05	0.000299	CcSEcCtD
Amiodarone—Urticaria—Hydrocortisone—psoriasis	2.72e-05	0.000299	CcSEcCtD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	2.71e-05	0.00103	CbGpPWpGaD
Amiodarone—Body temperature increased—Hydrocortisone—psoriasis	2.7e-05	0.000297	CcSEcCtD
Amiodarone—Abdominal pain—Hydrocortisone—psoriasis	2.7e-05	0.000297	CcSEcCtD
Amiodarone—ABCB1—Allograft Rejection—HLA-A—psoriasis	2.7e-05	0.00102	CbGpPWpGaD
Amiodarone—Asthenia—Mycophenolate mofetil—psoriasis	2.69e-05	0.000296	CcSEcCtD
Amiodarone—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	2.66e-05	0.00101	CbGpPWpGaD
Amiodarone—Pruritus—Mycophenolate mofetil—psoriasis	2.66e-05	0.000292	CcSEcCtD
Amiodarone—Feeling abnormal—Triamcinolone—psoriasis	2.66e-05	0.000292	CcSEcCtD
Amiodarone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.65e-05	0.00101	CbGpPWpGaD
Amiodarone—Anxiety—Prednisone—psoriasis	2.65e-05	0.000291	CcSEcCtD
Amiodarone—Alopecia—Methotrexate—psoriasis	2.65e-05	0.000291	CcSEcCtD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—JUN—psoriasis	2.65e-05	0.001	CbGpPWpGaD
Amiodarone—Insomnia—Dexamethasone—psoriasis	2.64e-05	0.00029	CcSEcCtD
Amiodarone—Insomnia—Betamethasone—psoriasis	2.64e-05	0.00029	CcSEcCtD
Amiodarone—Diarrhoea—Cyclosporine—psoriasis	2.63e-05	0.000289	CcSEcCtD
Amiodarone—Paraesthesia—Dexamethasone—psoriasis	2.63e-05	0.000288	CcSEcCtD
Amiodarone—Paraesthesia—Betamethasone—psoriasis	2.63e-05	0.000288	CcSEcCtD
Amiodarone—Discomfort—Prednisone—psoriasis	2.62e-05	0.000288	CcSEcCtD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.62e-05	0.000995	CbGpPWpGaD
Amiodarone—Erythema—Methotrexate—psoriasis	2.61e-05	0.000286	CcSEcCtD
Amiodarone—Hypersensitivity—Prednisolone—psoriasis	2.58e-05	0.000283	CcSEcCtD
Amiodarone—Dyspepsia—Betamethasone—psoriasis	2.57e-05	0.000283	CcSEcCtD
Amiodarone—Dyspepsia—Dexamethasone—psoriasis	2.57e-05	0.000283	CcSEcCtD
Amiodarone—Diarrhoea—Mycophenolate mofetil—psoriasis	2.57e-05	0.000282	CcSEcCtD
Amiodarone—Urticaria—Triamcinolone—psoriasis	2.56e-05	0.000281	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—psoriasis	2.55e-05	0.00028	CcSEcCtD
Amiodarone—Body temperature increased—Triamcinolone—psoriasis	2.55e-05	0.00028	CcSEcCtD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.55e-05	0.000966	CbGpPWpGaD
Amiodarone—Dizziness—Cyclosporine—psoriasis	2.55e-05	0.00028	CcSEcCtD
Amiodarone—Anaphylactic shock—Prednisone—psoriasis	2.55e-05	0.00028	CcSEcCtD
Amiodarone—Oedema—Prednisone—psoriasis	2.55e-05	0.00028	CcSEcCtD
Amiodarone—Decreased appetite—Betamethasone—psoriasis	2.54e-05	0.000279	CcSEcCtD
Amiodarone—Decreased appetite—Dexamethasone—psoriasis	2.54e-05	0.000279	CcSEcCtD
Amiodarone—CACNA2D2—Metabolism—CARM1—psoriasis	2.54e-05	0.000963	CbGpPWpGaD
Amiodarone—Infection—Prednisone—psoriasis	2.53e-05	0.000278	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Dexamethasone—psoriasis	2.52e-05	0.000277	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Betamethasone—psoriasis	2.52e-05	0.000277	CcSEcCtD
Amiodarone—Back pain—Methotrexate—psoriasis	2.52e-05	0.000277	CcSEcCtD
Amiodarone—Hypersensitivity—Hydrocortisone—psoriasis	2.52e-05	0.000277	CcSEcCtD
Amiodarone—Fatigue—Betamethasone—psoriasis	2.52e-05	0.000277	CcSEcCtD
Amiodarone—Fatigue—Dexamethasone—psoriasis	2.52e-05	0.000277	CcSEcCtD
Amiodarone—Shock—Prednisone—psoriasis	2.5e-05	0.000275	CcSEcCtD
Amiodarone—CACNA1H—Developmental Biology—PPARG—psoriasis	2.5e-05	0.000949	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—VDR—psoriasis	2.5e-05	0.000949	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—VDR—psoriasis	2.5e-05	0.000949	CbGpPWpGaD
Amiodarone—Pain—Dexamethasone—psoriasis	2.5e-05	0.000275	CcSEcCtD
Amiodarone—Pain—Betamethasone—psoriasis	2.5e-05	0.000275	CcSEcCtD
Amiodarone—Tachycardia—Prednisone—psoriasis	2.48e-05	0.000273	CcSEcCtD
Amiodarone—Dizziness—Mycophenolate mofetil—psoriasis	2.48e-05	0.000273	CcSEcCtD
Amiodarone—Skin disorder—Prednisone—psoriasis	2.47e-05	0.000272	CcSEcCtD
Amiodarone—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	2.46e-05	0.000935	CbGpPWpGaD
Amiodarone—Hyperhidrosis—Prednisone—psoriasis	2.46e-05	0.00027	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—psoriasis	2.46e-05	0.00027	CcSEcCtD
Amiodarone—Asthenia—Hydrocortisone—psoriasis	2.46e-05	0.00027	CcSEcCtD
Amiodarone—Vomiting—Cyclosporine—psoriasis	2.45e-05	0.000269	CcSEcCtD
Amiodarone—Rash—Cyclosporine—psoriasis	2.43e-05	0.000267	CcSEcCtD
Amiodarone—Anorexia—Prednisone—psoriasis	2.43e-05	0.000267	CcSEcCtD
Amiodarone—Dermatitis—Cyclosporine—psoriasis	2.43e-05	0.000266	CcSEcCtD
Amiodarone—Pruritus—Hydrocortisone—psoriasis	2.42e-05	0.000266	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—psoriasis	2.42e-05	0.000266	CcSEcCtD
Amiodarone—Headache—Cyclosporine—psoriasis	2.41e-05	0.000265	CcSEcCtD
Amiodarone—Feeling abnormal—Betamethasone—psoriasis	2.41e-05	0.000265	CcSEcCtD
Amiodarone—Feeling abnormal—Dexamethasone—psoriasis	2.41e-05	0.000265	CcSEcCtD
Amiodarone—Gastrointestinal pain—Dexamethasone—psoriasis	2.39e-05	0.000263	CcSEcCtD
Amiodarone—Gastrointestinal pain—Betamethasone—psoriasis	2.39e-05	0.000263	CcSEcCtD
Amiodarone—Vomiting—Mycophenolate mofetil—psoriasis	2.39e-05	0.000262	CcSEcCtD
Amiodarone—Hypersensitivity—Triamcinolone—psoriasis	2.37e-05	0.000261	CcSEcCtD
Amiodarone—Rash—Mycophenolate mofetil—psoriasis	2.37e-05	0.00026	CcSEcCtD
Amiodarone—Dermatitis—Mycophenolate mofetil—psoriasis	2.37e-05	0.00026	CcSEcCtD
Amiodarone—Headache—Mycophenolate mofetil—psoriasis	2.35e-05	0.000258	CcSEcCtD
Amiodarone—Malaise—Methotrexate—psoriasis	2.35e-05	0.000258	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—psoriasis	2.34e-05	0.000257	CcSEcCtD
Amiodarone—Diarrhoea—Hydrocortisone—psoriasis	2.34e-05	0.000257	CcSEcCtD
Amiodarone—Urticaria—Dexamethasone—psoriasis	2.32e-05	0.000255	CcSEcCtD
Amiodarone—Urticaria—Betamethasone—psoriasis	2.32e-05	0.000255	CcSEcCtD
Amiodarone—Dizziness—Prednisolone—psoriasis	2.32e-05	0.000254	CcSEcCtD
Amiodarone—Asthenia—Triamcinolone—psoriasis	2.31e-05	0.000254	CcSEcCtD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.31e-05	0.000877	CbGpPWpGaD
Amiodarone—Abdominal pain—Dexamethasone—psoriasis	2.31e-05	0.000254	CcSEcCtD
Amiodarone—Body temperature increased—Dexamethasone—psoriasis	2.31e-05	0.000254	CcSEcCtD
Amiodarone—Body temperature increased—Betamethasone—psoriasis	2.31e-05	0.000254	CcSEcCtD
Amiodarone—Abdominal pain—Betamethasone—psoriasis	2.31e-05	0.000254	CcSEcCtD
Amiodarone—Insomnia—Prednisone—psoriasis	2.3e-05	0.000253	CcSEcCtD
Amiodarone—Nausea—Cyclosporine—psoriasis	2.29e-05	0.000251	CcSEcCtD
Amiodarone—Paraesthesia—Prednisone—psoriasis	2.29e-05	0.000251	CcSEcCtD
Amiodarone—Pruritus—Triamcinolone—psoriasis	2.28e-05	0.00025	CcSEcCtD
Amiodarone—Cough—Methotrexate—psoriasis	2.27e-05	0.00025	CcSEcCtD
Amiodarone—Dizziness—Hydrocortisone—psoriasis	2.26e-05	0.000248	CcSEcCtD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.25e-05	0.000852	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.25e-05	0.000852	CbGpPWpGaD
Amiodarone—Dyspepsia—Prednisone—psoriasis	2.24e-05	0.000246	CcSEcCtD
Amiodarone—Nausea—Mycophenolate mofetil—psoriasis	2.23e-05	0.000245	CcSEcCtD
Amiodarone—Decreased appetite—Prednisone—psoriasis	2.21e-05	0.000243	CcSEcCtD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	2.21e-05	0.00084	CbGpPWpGaD
Amiodarone—Rash—Prednisolone—psoriasis	2.21e-05	0.000243	CcSEcCtD
Amiodarone—Dermatitis—Prednisolone—psoriasis	2.21e-05	0.000242	CcSEcCtD
Amiodarone—Fatigue—Prednisone—psoriasis	2.19e-05	0.000241	CcSEcCtD
Amiodarone—Headache—Prednisolone—psoriasis	2.19e-05	0.000241	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—psoriasis	2.19e-05	0.000241	CcSEcCtD
Amiodarone—CACNA1H—Developmental Biology—TYK2—psoriasis	2.19e-05	0.000832	CbGpPWpGaD
Amiodarone—EBP—Metabolism—CAT—psoriasis	2.19e-05	0.000831	CbGpPWpGaD
Amiodarone—Constipation—Prednisone—psoriasis	2.18e-05	0.000239	CcSEcCtD
Amiodarone—Vomiting—Hydrocortisone—psoriasis	2.18e-05	0.000239	CcSEcCtD
Amiodarone—CACNA1H—Axon guidance—VEGFA—psoriasis	2.17e-05	0.000824	CbGpPWpGaD
Amiodarone—Rash—Hydrocortisone—psoriasis	2.16e-05	0.000237	CcSEcCtD
Amiodarone—Dermatitis—Hydrocortisone—psoriasis	2.16e-05	0.000237	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—psoriasis	2.15e-05	0.000236	CcSEcCtD
Amiodarone—Headache—Hydrocortisone—psoriasis	2.14e-05	0.000235	CcSEcCtD
Amiodarone—CYP3A7—Metabolism—NDUFA5—psoriasis	2.13e-05	0.00081	CbGpPWpGaD
Amiodarone—Dizziness—Triamcinolone—psoriasis	2.13e-05	0.000234	CcSEcCtD
Amiodarone—Anaphylactic shock—Methotrexate—psoriasis	2.13e-05	0.000234	CcSEcCtD
Amiodarone—Infection—Methotrexate—psoriasis	2.11e-05	0.000232	CcSEcCtD
Amiodarone—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	2.11e-05	0.000799	CbGpPWpGaD
Amiodarone—Feeling abnormal—Prednisone—psoriasis	2.1e-05	0.00023	CcSEcCtD
Amiodarone—Asthenia—Dexamethasone—psoriasis	2.1e-05	0.00023	CcSEcCtD
Amiodarone—Asthenia—Betamethasone—psoriasis	2.1e-05	0.00023	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—psoriasis	2.08e-05	0.000229	CcSEcCtD
Amiodarone—Gastrointestinal pain—Prednisone—psoriasis	2.08e-05	0.000229	CcSEcCtD
Amiodarone—Nausea—Prednisolone—psoriasis	2.08e-05	0.000229	CcSEcCtD
Amiodarone—Pruritus—Betamethasone—psoriasis	2.07e-05	0.000227	CcSEcCtD
Amiodarone—Pruritus—Dexamethasone—psoriasis	2.07e-05	0.000227	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—psoriasis	2.07e-05	0.000227	CcSEcCtD
Amiodarone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	2.06e-05	0.000782	CbGpPWpGaD
Amiodarone—Hyperhidrosis—Methotrexate—psoriasis	2.06e-05	0.000226	CcSEcCtD
Amiodarone—Vomiting—Triamcinolone—psoriasis	2.05e-05	0.000225	CcSEcCtD
Amiodarone—Nausea—Hydrocortisone—psoriasis	2.03e-05	0.000223	CcSEcCtD
Amiodarone—Rash—Triamcinolone—psoriasis	2.03e-05	0.000223	CcSEcCtD
Amiodarone—Dermatitis—Triamcinolone—psoriasis	2.03e-05	0.000223	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—psoriasis	2.03e-05	0.000223	CcSEcCtD
Amiodarone—Urticaria—Prednisone—psoriasis	2.02e-05	0.000222	CcSEcCtD
Amiodarone—Headache—Triamcinolone—psoriasis	2.02e-05	0.000222	CcSEcCtD
Amiodarone—Abdominal pain—Prednisone—psoriasis	2.01e-05	0.000221	CcSEcCtD
Amiodarone—Body temperature increased—Prednisone—psoriasis	2.01e-05	0.000221	CcSEcCtD
Amiodarone—Diarrhoea—Dexamethasone—psoriasis	2e-05	0.00022	CcSEcCtD
Amiodarone—Diarrhoea—Betamethasone—psoriasis	2e-05	0.00022	CcSEcCtD
Amiodarone—Hypotension—Methotrexate—psoriasis	1.99e-05	0.000218	CcSEcCtD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—TNF—psoriasis	1.98e-05	0.000752	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NDUFA5—psoriasis	1.96e-05	0.000742	CbGpPWpGaD
Amiodarone—Dizziness—Dexamethasone—psoriasis	1.93e-05	0.000212	CcSEcCtD
Amiodarone—Dizziness—Betamethasone—psoriasis	1.93e-05	0.000212	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—psoriasis	1.92e-05	0.000211	CcSEcCtD
Amiodarone—Nausea—Triamcinolone—psoriasis	1.91e-05	0.00021	CcSEcCtD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.91e-05	0.000726	CbGpPWpGaD
Amiodarone—Paraesthesia—Methotrexate—psoriasis	1.91e-05	0.00021	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—psoriasis	1.9e-05	0.000208	CcSEcCtD
Amiodarone—Hypersensitivity—Prednisone—psoriasis	1.88e-05	0.000206	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—psoriasis	1.87e-05	0.000206	CcSEcCtD
Amiodarone—Vomiting—Betamethasone—psoriasis	1.86e-05	0.000204	CcSEcCtD
Amiodarone—Vomiting—Dexamethasone—psoriasis	1.86e-05	0.000204	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—psoriasis	1.85e-05	0.000203	CcSEcCtD
Amiodarone—Rash—Betamethasone—psoriasis	1.84e-05	0.000202	CcSEcCtD
Amiodarone—Rash—Dexamethasone—psoriasis	1.84e-05	0.000202	CcSEcCtD
Amiodarone—Dermatitis—Dexamethasone—psoriasis	1.84e-05	0.000202	CcSEcCtD
Amiodarone—Dermatitis—Betamethasone—psoriasis	1.84e-05	0.000202	CcSEcCtD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	1.84e-05	0.000699	CbGpPWpGaD
Amiodarone—Gastrointestinal disorder—Methotrexate—psoriasis	1.84e-05	0.000202	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—psoriasis	1.83e-05	0.000201	CcSEcCtD
Amiodarone—Headache—Betamethasone—psoriasis	1.83e-05	0.000201	CcSEcCtD
Amiodarone—Headache—Dexamethasone—psoriasis	1.83e-05	0.000201	CcSEcCtD
Amiodarone—Asthenia—Prednisone—psoriasis	1.83e-05	0.000201	CcSEcCtD
Amiodarone—Pain—Methotrexate—psoriasis	1.82e-05	0.0002	CcSEcCtD
Amiodarone—CYP3A7—Metabolism—CYP2S1—psoriasis	1.81e-05	0.000688	CbGpPWpGaD
Amiodarone—Pruritus—Prednisone—psoriasis	1.8e-05	0.000198	CcSEcCtD
Amiodarone—ABCB1—Allograft Rejection—IFNG—psoriasis	1.8e-05	0.000682	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	1.79e-05	0.000681	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HCAR2—psoriasis	1.76e-05	0.000668	CbGpPWpGaD
Amiodarone—Feeling abnormal—Methotrexate—psoriasis	1.75e-05	0.000193	CcSEcCtD
Amiodarone—THRB—Gene Expression—PPARG—psoriasis	1.74e-05	0.000662	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—PPARG—psoriasis	1.74e-05	0.000662	CbGpPWpGaD
Amiodarone—Diarrhoea—Prednisone—psoriasis	1.74e-05	0.000191	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methotrexate—psoriasis	1.74e-05	0.000191	CcSEcCtD
Amiodarone—Nausea—Betamethasone—psoriasis	1.74e-05	0.000191	CcSEcCtD
Amiodarone—Nausea—Dexamethasone—psoriasis	1.74e-05	0.000191	CcSEcCtD
Amiodarone—CACNA1H—Developmental Biology—NFKB1—psoriasis	1.71e-05	0.000648	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CCL20—psoriasis	1.7e-05	0.000647	CbGpPWpGaD
Amiodarone—EBP—Metabolism—APOE—psoriasis	1.7e-05	0.000646	CbGpPWpGaD
Amiodarone—Urticaria—Methotrexate—psoriasis	1.69e-05	0.000186	CcSEcCtD
Amiodarone—Dizziness—Prednisone—psoriasis	1.68e-05	0.000185	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—psoriasis	1.68e-05	0.000185	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—psoriasis	1.68e-05	0.000185	CcSEcCtD
Amiodarone—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.67e-05	0.000635	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.67e-05	0.000634	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP2S1—psoriasis	1.66e-05	0.000631	CbGpPWpGaD
Amiodarone—Vomiting—Prednisone—psoriasis	1.62e-05	0.000178	CcSEcCtD
Amiodarone—Rash—Prednisone—psoriasis	1.61e-05	0.000176	CcSEcCtD
Amiodarone—Dermatitis—Prednisone—psoriasis	1.6e-05	0.000176	CcSEcCtD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—IL6—psoriasis	1.6e-05	0.000607	CbGpPWpGaD
Amiodarone—Headache—Prednisone—psoriasis	1.59e-05	0.000175	CcSEcCtD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.57e-05	0.000595	CbGpPWpGaD
Amiodarone—Hypersensitivity—Methotrexate—psoriasis	1.57e-05	0.000172	CcSEcCtD
Amiodarone—CACNA2D2—Metabolism—CAT—psoriasis	1.56e-05	0.000592	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—VEGFA—psoriasis	1.55e-05	0.000588	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CCL20—psoriasis	1.55e-05	0.000587	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NDUFA5—psoriasis	1.54e-05	0.000585	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—STAT3—psoriasis	1.53e-05	0.000582	CbGpPWpGaD
Amiodarone—Asthenia—Methotrexate—psoriasis	1.53e-05	0.000168	CcSEcCtD
Amiodarone—ADRB1—Signaling Pathways—TAGAP—psoriasis	1.53e-05	0.000579	CbGpPWpGaD
Amiodarone—Nausea—Prednisone—psoriasis	1.51e-05	0.000166	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—psoriasis	1.51e-05	0.000165	CcSEcCtD
Amiodarone—CACNA1H—Axon guidance—IL6—psoriasis	1.5e-05	0.00057	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PPARG—psoriasis	1.48e-05	0.000562	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NDUFA5—psoriasis	1.46e-05	0.000553	CbGpPWpGaD
Amiodarone—Diarrhoea—Methotrexate—psoriasis	1.46e-05	0.00016	CcSEcCtD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.43e-05	0.000544	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.43e-05	0.000544	CbGpPWpGaD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	1.42e-05	0.000539	CbGpPWpGaD
Amiodarone—Dizziness—Methotrexate—psoriasis	1.41e-05	0.000155	CcSEcCtD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.38e-05	0.000523	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.36e-05	0.000516	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.36e-05	0.000515	CbGpPWpGaD
Amiodarone—Vomiting—Methotrexate—psoriasis	1.35e-05	0.000149	CcSEcCtD
Amiodarone—Rash—Methotrexate—psoriasis	1.34e-05	0.000147	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—psoriasis	1.34e-05	0.000147	CcSEcCtD
Amiodarone—CYP2C8—Metabolism—NDUFA5—psoriasis	1.34e-05	0.000507	CbGpPWpGaD
Amiodarone—Headache—Methotrexate—psoriasis	1.33e-05	0.000146	CcSEcCtD
Amiodarone—CACNA1H—Developmental Biology—TNF—psoriasis	1.33e-05	0.000504	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP2S1—psoriasis	1.31e-05	0.000498	CbGpPWpGaD
Amiodarone—Nausea—Methotrexate—psoriasis	1.26e-05	0.000139	CcSEcCtD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.25e-05	0.000473	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CYP2S1—psoriasis	1.24e-05	0.00047	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—APOE—psoriasis	1.21e-05	0.00046	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NDUFA5—psoriasis	1.19e-05	0.000452	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—TNF—psoriasis	1.16e-05	0.000442	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NDUFA5—psoriasis	1.16e-05	0.000442	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.16e-05	0.000439	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP2S1—psoriasis	1.14e-05	0.000431	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.11e-05	0.000422	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NDUFA5—psoriasis	1.1e-05	0.000416	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NDUFA5—psoriasis	1.09e-05	0.000413	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.08e-05	0.00041	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—IL6—psoriasis	1.07e-05	0.000407	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.07e-05	0.000406	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PPARG—psoriasis	1.06e-05	0.000401	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.03e-05	0.000392	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP2S1—psoriasis	1.01e-05	0.000385	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.01e-05	0.000385	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP2S1—psoriasis	9.89e-06	0.000375	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP2S1—psoriasis	9.32e-06	0.000354	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NDUFA5—psoriasis	9.29e-06	0.000353	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP2S1—psoriasis	9.24e-06	0.000351	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCL20—psoriasis	9.14e-06	0.000347	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CARM1—psoriasis	8.86e-06	0.000336	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.66e-06	0.000329	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CXCL8—psoriasis	8.14e-06	0.000309	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CARM1—psoriasis	8.12e-06	0.000308	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP2S1—psoriasis	7.9e-06	0.0003	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	7.67e-06	0.000291	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	7.38e-06	0.00028	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NDUFA5—psoriasis	7.17e-06	0.000272	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	6.7e-06	0.000254	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.49e-06	0.000246	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CARM1—psoriasis	6.4e-06	0.000243	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2S1—psoriasis	6.1e-06	0.000231	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CARM1—psoriasis	6.05e-06	0.00023	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.95e-06	0.000226	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	5.74e-06	0.000218	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.65e-06	0.000215	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CARM1—psoriasis	5.55e-06	0.00021	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CAT—psoriasis	5.45e-06	0.000207	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.31e-06	0.000202	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.18e-06	0.000197	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	5.06e-06	0.000192	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SOCS1—psoriasis	5.03e-06	0.000191	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CAT—psoriasis	4.99e-06	0.00019	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CARM1—psoriasis	4.95e-06	0.000188	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.84e-06	0.000184	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CARM1—psoriasis	4.83e-06	0.000183	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—TYK2—psoriasis	4.8e-06	0.000182	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.63e-06	0.000176	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCL8—psoriasis	4.6e-06	0.000175	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CARM1—psoriasis	4.55e-06	0.000173	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CARM1—psoriasis	4.51e-06	0.000171	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—APOE—psoriasis	4.23e-06	0.000161	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.22e-06	0.00016	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCL8—psoriasis	4.18e-06	0.000159	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.14e-06	0.000157	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CAT—psoriasis	3.94e-06	0.000149	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—APOE—psoriasis	3.88e-06	0.000147	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CARM1—psoriasis	3.86e-06	0.000146	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CAT—psoriasis	3.72e-06	0.000141	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—LEP—psoriasis	3.71e-06	0.000141	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APOE—psoriasis	3.71e-06	0.000141	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PPARG—psoriasis	3.69e-06	0.00014	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.61e-06	0.000137	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NFKBIA—psoriasis	3.46e-06	0.000131	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CAT—psoriasis	3.41e-06	0.000129	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PPARG—psoriasis	3.38e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—APOE—psoriasis	3.06e-06	0.000116	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CAT—psoriasis	3.04e-06	0.000116	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CARM1—psoriasis	2.98e-06	0.000113	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CAT—psoriasis	2.97e-06	0.000113	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—APOE—psoriasis	2.89e-06	0.00011	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TYK2—psoriasis	2.83e-06	0.000108	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CAT—psoriasis	2.8e-06	0.000106	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CAT—psoriasis	2.78e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPARG—psoriasis	2.67e-06	0.000101	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—APOE—psoriasis	2.65e-06	0.000101	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPARG—psoriasis	2.52e-06	9.56e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—psoriasis	2.47e-06	9.37e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CAT—psoriasis	2.37e-06	9e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—APOE—psoriasis	2.37e-06	8.98e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6—psoriasis	2.35e-06	8.91e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—APOE—psoriasis	2.31e-06	8.76e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPARG—psoriasis	2.31e-06	8.76e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—JUN—psoriasis	2.29e-06	8.71e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NFKB1—psoriasis	2.21e-06	8.38e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—APOE—psoriasis	2.18e-06	8.26e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—APOE—psoriasis	2.16e-06	8.19e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARG—psoriasis	2.06e-06	7.82e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARG—psoriasis	2.01e-06	7.63e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—psoriasis	2e-06	7.61e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—psoriasis	1.98e-06	7.53e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARG—psoriasis	1.9e-06	7.19e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARG—psoriasis	1.88e-06	7.13e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—APOE—psoriasis	1.84e-06	7e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CAT—psoriasis	1.83e-06	6.95e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARG—psoriasis	1.61e-06	6.09e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—psoriasis	1.51e-06	5.75e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APOE—psoriasis	1.42e-06	5.4e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6—psoriasis	1.39e-06	5.26e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARG—psoriasis	1.24e-06	4.7e-05	CbGpPWpGaD
